title: Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
authors.affiliation: Department of Immunology Research, Merck, Sharp & Dohme Research Laboratories, Rahway, NJ 07065.
authors.forename: N H
authors.initials: NH
authors.lastname: Sigal
authors.forename: F J
authors.initials: FJ
authors.lastname: Dumont
authors.forename: J J
authors.initials: JJ
authors.lastname: Siekierka
authors.forename: G
authors.initials: G
authors.lastname: Wiederrecht
authors.forename: S A
authors.initials: SA
authors.lastname: Parent
authors.forename: L
authors.initials: L
authors.lastname: Brizuela
mesh_terms: D000591:Amino Acid Isomerases / Q000235:genetics / Q000502:physiology; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology*; D002872:Chromosome Deletion; D016572:Cyclosporine / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D009492:Neurospora crassa / Q000235:genetics; D019696:Peptidylprolyl Isomerase; D012441:Saccharomyces cerevisiae / Q000235:genetics; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D022021:Tacrolimus Binding Proteins
chemical_list: D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000591:Amino Acid Isomerases; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus